Sex Differences in the Social Brain
社交大脑中的性别差异
基本信息
- 批准号:9310365
- 负责人:
- 金额:$ 67.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-05 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:Aggressive behaviorAgonistAgonistic BehaviorAnxiety DisordersAttentionBehavioralBindingBrainClinicalConfocal MicroscopyDataDevelopmentDrug TargetingExhibitsFemaleFluoxetineGenderGoalsHamstersHealthHypothalamic structureIncidenceIndividualInjection of therapeutic agentKnowledgeLeadMacaca mulattaMaintenanceMesocricetus auratusMood DisordersNeuronsOutcomePatternPharmacotherapyPhenotypePhysiologicalPositron-Emission TomographyPredispositionReceptor ActivationReceptor InhibitionResistanceRoleSelective Serotonin Reuptake InhibitorSeriesSerotoninSerotonin Receptor 5-HT1ASex CharacteristicsSiteSocial InteractionSocial statusStressTestingTherapeuticVasopressinsWomanWorkcopingdrug developmentinnovationmalemenneurochemistryneuromechanismneuropsychiatric disorderreceptorreceptor bindingsocialsocial stressstem
项目摘要
PROJECT SUMMARY
In most mammalian species, social interactions among individuals of the same species are governed by
dominance relationships. These hierarchical relationships are established and maintained by agonistic
behaviors, including aggression. Importantly, recent data indicate that the neural mechanisms underlying
aggression and attaining dominance produce a phenotype that is resistant to social stress while the
mechanisms underlying subordinate status produce a social stress-susceptible phenotype that may result in
a number of adverse behavioral and physiological outcomes. Despite the relationship between social status
and stress, the neurochemical mechanisms that underlie dominance have received only limited attention in
males and almost no attention in females. This project will fill this critical gap in our knowledge by testing an
integrated series of hypotheses using Syrian hamsters and rhesus monkeys. This project will critically test the
overarching hypothesis that the agonistic behaviors responsible for the formation and maintenance of
dominance relationships are regulated in dramatically different ways by vasopressin (AVP) and serotonin (5-
HT) in males and females. Specifically, we propose that activation of AVP and inhibition of 5-HT promotes
dominant status and a stress resistant phenotype in MALES while producing subordinate status and a stress
susceptible phenotype in FEMALES. In contrast, inhibition of AVP and activation of 5-HT promotes
dominance and a stress resistant phenotype in FEMALES while producing subordinate status and a stress
susceptible phenotype in MALES. Together, these data will significantly expand our knowledge of sex
differences in the neurochemical mechanisms that define social phenotypes and will provide innovative
gender specific strategies for promoting resistance to social stress. The data obtained in this project could
have an almost immediate clinical impact by guiding drug treatments for stress reduction in men and women
as well as guiding drug development by emphasizing the role of AVP-targeted drugs in males and 5-HT-
targeted drugs in females.
项目概要
在大多数哺乳动物物种中,同一物种个体之间的社会互动受以下因素支配:
支配关系。这些等级关系是通过竞争性建立和维持的
行为,包括攻击性。重要的是,最近的数据表明,潜在的神经机制
攻击性和获得统治地位会产生一种能够抵抗社会压力的表型,而
从属地位的机制会产生一种对社会压力敏感的表型,这可能会导致
许多不良的行为和生理结果。尽管有社会地位的关系
和压力等方面,支配地位背后的神经化学机制只受到了有限的关注。
男性几乎没有关注女性。该项目将通过测试
使用叙利亚仓鼠和恒河猴整合了一系列假设。该项目将严格测试
总体假设是,竞争行为负责形成和维持
加压素 (AVP) 和血清素 (5-
HT)在男性和女性中。具体来说,我们建议 AVP 的激活和 5-HT 的抑制促进
男性的主导地位和抗应激表型,同时产生从属地位和压力
女性易感表型。相反,抑制 AVP 和激活 5-HT 可促进
女性的主导地位和抗压表型,同时产生从属地位和压力
男性易感表型。总之,这些数据将极大地扩展我们对性的了解
定义社会表型的神经化学机制的差异将提供创新
促进抵抗社会压力的针对性别的战略。本项目获得的数据可以
通过指导男性和女性减轻压力的药物治疗,产生几乎立竿见影的临床影响
以及通过强调 AVP 靶向药物在男性和 5-HT- 中的作用来指导药物开发
女性靶向药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H. Elliott Albers其他文献
Sex-dependent regulation of social reward by oxytocin: an inverted U hypothesis
催产素对社会奖赏的性别依赖性调节:倒 U 型假说
- DOI:
10.1038/s41386-018-0129-2 - 发表时间:
2018-06-23 - 期刊:
- 影响因子:7.100
- 作者:
Johnathan M. Borland;James K. Rilling;Kyle J. Frantz;H. Elliott Albers - 通讯作者:
H. Elliott Albers
H. Elliott Albers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H. Elliott Albers', 18)}}的其他基金
Sex-dependent regulation of social reward by oxytocin in the mesolimbic reward circuitry
中脑边缘奖励回路中催产素对社会奖励的性别依赖性调节
- 批准号:
10380844 - 财政年份:2021
- 资助金额:
$ 67.53万 - 项目类别:
Sex-dependent regulation of social reward by oxytocin in the mesolimbic reward circuitry
中脑边缘奖励回路中催产素对社会奖励的性别依赖性调节
- 批准号:
10569581 - 财政年份:2021
- 资助金额:
$ 67.53万 - 项目类别:
Advances in the Study of Social Neuroendocrinology
社会神经内分泌学研究进展
- 批准号:
9353869 - 财政年份:2016
- 资助金额:
$ 67.53万 - 项目类别:
Communication within the Suprachiasmatic Neural Circadian Network
视交叉上神经昼夜节律网络内的通信
- 批准号:
8686095 - 财政年份:2012
- 资助金额:
$ 67.53万 - 项目类别:
Communication within the Suprachiasmatic Neural Circadian Network
视交叉上神经昼夜节律网络内的通信
- 批准号:
8535854 - 财政年份:2012
- 资助金额:
$ 67.53万 - 项目类别:
Communication within the Suprachiasmatic Neural Circadian Network
视交叉上神经昼夜节律网络内的通信
- 批准号:
8852717 - 财政年份:2012
- 资助金额:
$ 67.53万 - 项目类别:
Communication within the Suprachiasmatic Neural Circadian Network
视交叉上神经昼夜节律网络内的通信
- 批准号:
9070006 - 财政年份:2012
- 资助金额:
$ 67.53万 - 项目类别:
Communication within the Suprachiasmatic Neural Circadian Network
视交叉上神经昼夜节律网络内的通信
- 批准号:
8437845 - 财政年份:2012
- 资助金额:
$ 67.53万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 67.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 67.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 67.53万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 67.53万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 67.53万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 67.53万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 67.53万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 67.53万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 67.53万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 67.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




